Neuron23

Last updated: May 06, 2024

Founder Adam Knight

Country: USA | Funding: $213.5M (+)

Website: https://neuron23.com/

Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.